NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $144,000 | -28.7% | 1,895 | -20.9% | 0.04% | -25.9% |
| Q2 2022 | $202,000 | +225.8% | 2,395 | +237.8% | 0.05% | +260.0% |
| Q1 2022 | $62,000 | -19.5% | 709 | -19.9% | 0.02% | -16.7% |
| Q4 2021 | $77,000 | +6.9% | 885 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $72,000 | -10.0% | 885 | 0.0% | 0.02% | -10.0% |
| Q2 2021 | $80,000 | +5.3% | 885 | 0.0% | 0.02% | -4.8% |
| Q1 2021 | $76,000 | -9.5% | 885 | 0.0% | 0.02% | -19.2% |
| Q4 2020 | $84,000 | +10.5% | 885 | 0.0% | 0.03% | -3.7% |
| Q3 2020 | $76,000 | -1.3% | 885 | 0.0% | 0.03% | -6.9% |
| Q2 2020 | $77,000 | +8.5% | 885 | 0.0% | 0.03% | -14.7% |
| Q1 2020 | $71,000 | +6.0% | 885 | +24.8% | 0.03% | +54.5% |
| Q4 2019 | $67,000 | +9.8% | 709 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $61,000 | -6.2% | 709 | 0.0% | 0.02% | -8.3% |
| Q2 2019 | $65,000 | – | 709 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |